NaviGate Cardiac Structures, Inc., (NCSI)

NaviGate Cardiac Structures, Inc., (NCSI) is an early-stage company focused on developing transcatheter solutions for the treatment of atrioventricular valve regurgitation. The NaviGate valve-based technology was licensed from Cleveland Clinic and further modified and developed by NCSI. Given the unmet clinical need for patients with moderate or greater functional valve regurgitation (FTR)/ tricuspid insufficiency, NCSI is developing a catheter-guided atrioventricular valved stent for replacement of a failing tricuspid valve. Innovative anchoring mechanisms serve to secure and maintain positioning of the replacement valve.